Abstract:Iron overload and cellular senescence have been implicated in liver fibrosis, but their possible mechanistic connection has not been explored. To address this, we have delved into the role of iron and senescence in an experimental model of chronic liver injury, analyzing whether an iron chelator would prevent liver fibrosis by decreasing hepatocyte senescence. The model of carbon tetrachloride (CCl4) in mice was used as an experimental model of liver fibrosis. Results demonstrated that during the progression of liver fibrosis, accumulation of iron occurs, concomitant with the appearance of fibrotic areas and cells undergoing senescence. Isolated parenchymal hepatocytes from CCl4-treated mice present a gene transcriptomic signature compatible with iron accumulation and senescence, which correlates with induction of Reactive Oxygen Species (ROS)-related genes, activation of the Transforming Growth Factor-beta (TGF-β) pathway and inhibition of oxidative metabolism. Analysis of the iron-related gene signature in a published single-cell RNA-seq dataset from CCl4-treated livers showed iron accumulation correlating with senescence in other non-parenchymal liver cells. Treatment with deferiprone, an iron chelator, attenuated iron accumulation, fibrosis and senescence, concomitant with relevant changes in the senescent-associated secretome (SASP), which switched toward a more anti-inflammatory profile of cytokines. In vitro experiments in human hepatocyte HH4 cells demonstrated that iron accumulates in response to a senescence-inducing reagent, doxorubicin, being deferiprone able to prevent senescence and SASP, attenuating growth arrest and cell death. However, deferiprone did not significantly affect senescence induced by two different agents (doxorubicin and deoxycholic acid) or activation markers in human hepatic stellate LX-2 cells. Transcriptomic data from patients with different etiologies demonstrated the relevance of iron accumulation in the progression of liver chronic damage and fibrosis, correlating with a SASP-related gene signature and pivotal hallmarks of fibrotic changes. Altogether, our study establishes iron accumulation as a clinically exploitable driver to attenuate pathological senescence in hepatocytes.

Iron derived from NCOA4-mediated ferritinophagy causes cellular senescence via the cGAS-STING pathway

Changes in Iron-Regulatory Proteins in the Aged Rodent Neural Retina

Iron retardation in lysosome protects senescent cells from ferroptosis

Iron overload induces cerebral endothelial senescence in aged mice and in primary culture in a sex-dependent manner

Interferon-γ induces retinal pigment epithelial cell Ferroptosis by a JAK1-2/STAT1/SLC7A11 signaling pathway in Age-related Macular Degeneration

Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction

Ferroptosis as a potential therapeutic target for age-related macular degeneration

Implication of Ferroptosis in Aging

Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway

Iron Overload Induces Apoptosis and Cytoprotective Autophagy Regulated by ROS Generation in Mc3t3-E1 Cells

Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression

Inflammatory adipose activates a nutritional immunity pathway leading to retinal dysfunction

Aging leads to elevation of O-GlcNAcylation and disruption of mitochondrial homeostasis in retina.

Iron Chelator Deferiprone Restores Iron Homeostasis and Inhibits Retinal Neovascularization in Experimental Neovascular Age-Related Macular Degeneration

Pro-ferroptotic Signaling Promotes Arterial Aging Via Vascular Smooth Muscle Cell Senescence

Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease

[Transition metal accumulation and cellular senescence]

Oxidative Stress-Induced Cellular Senescence in Aging Retina and Age-Related Macular Degeneration

Embryonal erythropoiesis and aging exploit ferroptosis

Ferritinophagy: A novel insight into the double-edged sword in ferritinophagy-ferroptosis axis and human diseases

The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?